Title |
Biomarkers in psychiatry: drawbacks and potential for misuse
|
---|---|
Published in |
International Archives of Medicine, January 2010
|
DOI | 10.1186/1755-7682-3-1 |
Pubmed ID | |
Authors |
Shaheen E Lakhan, Karen Vieira, Elissa Hamlat |
Abstract |
For more than 20 years, researchers have attempted to identify diagnostic and prognostic biomarkers for psychiatric disorders including schizophrenia, major (unipolar) depression, and bipolar disorder. Advocates of this research contend that identifying such biomarkers will aid in the diagnosis of these disorders, as well as the possible development of effective psychiatric medications to treat them. Currently, there are no diagnostic tests available. This is largely due to the multi-factorial nature of psychiatric disorders. Biomarker testing of individuals is also prohibitively expensive because significant expertise is required to conduct tests and follow-up counseling for the patient is often necessary. It is cautioned that widespread biomarker testing could lead to negative consequences such as discrimination in health insurance and employment, as well as selective abortion. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United States | 4 | 4% |
Italy | 1 | <1% |
Canada | 1 | <1% |
Brazil | 1 | <1% |
Unknown | 103 | 94% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 22 | 20% |
Researcher | 18 | 16% |
Student > Bachelor | 14 | 13% |
Student > Master | 14 | 13% |
Student > Doctoral Student | 8 | 7% |
Other | 22 | 20% |
Unknown | 12 | 11% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 22 | 20% |
Psychology | 21 | 19% |
Neuroscience | 11 | 10% |
Agricultural and Biological Sciences | 10 | 9% |
Biochemistry, Genetics and Molecular Biology | 6 | 5% |
Other | 16 | 15% |
Unknown | 24 | 22% |